David Dalgarno

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Bradford Dahms - Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Dalgarno:

Company Role Class Num Shares Value Price $ Report Date Ownership
Theseus Pharmaceuticals, Inc. Chief Technical Officer Common Stock 388,324 $1,184,388 $3.05 06 Oct 2021 Direct
Theseus Pharmaceuticals, Inc. Chief Technical Officer Stock Option (right to buy) 130,000 18 Feb 2022 Direct

Insider Reports Filed by David Dalgarno

Symbol Company Period Transactions Value $ Form Type Role Filing Time
THRX Theseus Pharmaceuticals, Inc. 18 Feb 2022 1 $0 4 Chief Technical Officer 23 Feb 2022, 19:00
THRX Theseus Pharmaceuticals, Inc. 06 Oct 2021 0 $0 3 Chief Technical Officer 06 Oct 2021, 19:00